Faculty who have authored publication A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies.
Name | Title | Department | Institution |
---|---|---|---|
Razelle Kurzrock MD | Center Associate Director, Professor | Medicine | Medical College of Wisconsin |